For example, taxa like the mole-rat Spalax and the Salamander Axolotl have adapted their p53-DBS in hypoxic environments with certain substitutions identical to human tumour-associated mutations that inhibit hypoxia-induced apoptosis in favour of cell cycle arrest [19, 20]. The gene discussed is TP53; the disease is neoplasm.